Clinical Trials

Participants in clinical trials can play a more active role in their own health care, gain access to new research treatments before they are widely available, and help others by contributing to medical research.

Here at VISOC, we pride ourselves on cutting edge therapy and the development of new technologies to improve patient care. We are currently participating in a number of clinical trials involving several therapeutic areas which are listed below.

Next to the title of each trial is the Clinical Trials.gov Identifier number. You can go to www.clinicaltrials.gov to learn more about each trial. If you are interested in learning more about your participation, or the participation of a loved one, please contact Doreen Robinson, RN, CCRC at (714) 560-4450 or doreen@visoc.org.

  • Carotid Stenosis
    • Carotid Stenting
    • Carotid Endarterectomy
    • ACT1 - NCT00106938 (Open to Enrollment)
      Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease
    • CHOICE - NCT00406055 (Open to Enrollment)
      Carotid Stenting For High Surgical-Risk Patients; Evaluating Outcomes Through The Collection Of Clinical Evidence
    • SAPPHIRE WorldWide - NCT00403078 (Open to Enrollment)
      Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
  • Critical Limb Ischemia
    • Angiogenesis
    • Lower extremity balloon angioplasty & stent placement
    • Lower extremity bypass
    • Drug eluting balloon angioplasty (Coming Soon!)
    • VIROMED - NCT01064440 (Open to Enrollment)
      A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subject With Critical Limb Ischemia
    • The BEST (Endovascular versus Surgical Therapy) Trial (Coming Soon!)
      A prospective, randomized, open label, multicenter, intent to treat, superiority trial comparing best surgical versus best endovascular revascularization in 2,100 patients with infrainguinal PAD and CLI.
    • Tamaris - NCT00566657 (Closed to Enrollment)
      A Randomized Double-Blind Placebo-Controlled Parallel Group Study of the Efficacy and Safety of XRP0038/NV1FGF on Amputation or Any Death in Critical Limb Ischemia Patients With Skin Lesions
  • Deep Vein Thrombosis
    • ATTRACT - NCT00790335 (Open to Enrollment)
      Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
  • Pulmonary Embolism
    • RETRIEVE 2 - NCT01120509 (Open to Enrollment)
      Crux Biomedical Evaluation of the Crux Inferior Vena Cava Filter System 2

    • Other areas of clinical trial experience:

  • Hypertension
    • Carotid artery baroreceptor stimulation
  • Renal Artery Stenosis
    • Renal artery stenting vs. drug therapy
  • Acute Ischemic Stroke
    • Device assisted thrombectomy
  • Cerebral Aneurysms (symptomatic & asymptomatic)
    • Endovascular coiling
  • Surgical Hemostasis
    • Peripheral Arterial Bypass
    • Hemodialysis procedures

To find out more information, please contact:

Doreen Robinson, RN, CCRC
Phone: (714) 560-4450
E-Mail: doreen@visoc.org
View Biography